Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATHA | DARE | NEUP | ||
| Company | Athira Pharma Inc | Dare Bioscience Inc | Neuphoria Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.30 | 1.8000 | 4.77 | ||
| High | 7.35 | 1.8300 | 4.77 | ||
| Low | 6.62 | 1.7501 | 4.49 | ||
| Latest | 6.75 | 1.7800 | 4.57 | ||
| Change | -0.44 | -0.0500 | -0.21 | ||
| % Change | -6.12% | -2.73% | -4.39% | ||
| Volume | 70,300 | 10,000 | 42,900 | ||
| 20-Day Average Volume | 3,212,845 | 110,310 | 58,165 | ||
| Previous Close | 7.19 | 1.8300 | 4.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 6.34 | 1.6175 | 4.44 | ||
| 20-Day Raw Stochastic | 64.69% | 79.69% | 77.66% | ||
| 20-Day Relative Strength | 59.15 | 55.26 | 53.27 | ||
| Weighted Alpha | -9.76 | -44.51 | -5.89 | ||
| Today's Opinion | 100% Buy | 56% Sell | 8% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 8% Buy | ||
| Last Month's Opinion | 48% Buy | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.02% since 01/02/26 | -1.66% since 04/06/26 | +5.79% since 04/06/26 | ||
| Low | 6.41 on 01/05/26 | 1.7400 on 04/07/26 | 4.25 on 04/07/26 | ||
| High | 7.45 on 01/08/26 | 1.8800 on 04/10/26 | 4.78 on 04/10/26 | ||
| 1-Month | |||||
| %Chg | +68.33% since 12/09/25 | +23.61% since 03/13/26 | +0.66% since 03/13/26 | ||
| Low | 3.80 on 12/16/25 | 1.2700 on 03/20/26 | 3.84 on 03/30/26 | ||
| High | 8.36 on 12/18/25 | 1.9100 on 04/01/26 | 4.78 on 04/10/26 | ||
| 3-Month | |||||
| %Chg | +72.19% since 10/09/25 | -7.77% since 01/13/26 | +9.59% since 01/13/26 | ||
| Low | 3.60 on 10/16/25 | 1.2700 on 03/20/26 | 3.84 on 03/30/26 | ||
| High | 8.36 on 12/18/25 | 2.0700 on 01/14/26 | 4.94 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +66.87% since 07/09/25 | -16.04% since 10/13/25 | -72.67% since 10/13/25 | ||
| Low | 3.24 on 08/01/25 | 1.2700 on 03/20/26 | 3.64 on 12/29/25 | ||
| High | 8.36 on 12/18/25 | 2.5400 on 12/15/25 | 17.90 on 10/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,621 | 26,645 | 25,769 | ||
| Shares Outstanding, K | 3,944 | 14,560 | 5,391 | ||
| Annual Sales | 0 | 1,030,000 | 15,650,000 | ||
| Annual Net Income | -96,940,000 | -13,400,000 | -370,000 | ||
| Last Quarter Sales | 0 | 1,020,000 | 0 | ||
| Last Quarter Net Income | -6,610,000 | -1,440,000 | 1,860,000 | ||
| 60-Month Beta | 2.79 | 0.90 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.68 on 11/06/25 | -0.02 on 03/26/26 | -0.77 on 02/17/26 | ||
| Latest Earnings Date | 02/26/26 | 05/12/26 | 05/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||